LENZ Therapeutics
LENZ
#9742
Rank
HK$0.73 B
Marketcap
HK$23.24
Share price
-11.23%
Change (1 day)
-89.90%
Change (1 year)

Operating Margin for LENZ Therapeutics (LENZ)

Operating Margin as of November 2026 (TTM): -1,134.93%

According to LENZ Therapeutics's latest financial reports and stock price the company's current Operating Margin is -1,134.93%. At the end of 2025 the company had an Operating Margin of -477.46%.

Operating Margin history for LENZ Therapeutics from 2026 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-477.46%
2022-69.89%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.